Milroy's primary congenital lymphedema in a male infant and review of the literature

In Vivo

Volumn 24, Issue 3, 2010, Pages 309-314

  Kitsiou Tzeli, Sophia ^a   Vrettou, Christina ^a   Leze, Eleni ^a   Makrythanasis, Periklis ^b   Kanavakis, Emmanouel ^a   Willems, Patrick ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c Genetic Diagnostics Belgium   (Belgium)

Author keywords

Congenital lymphedema; FLT4 gene; Milroy disease

Indexed keywords

ASPARTIC ACID; HISTIDINE; VASCULOTROPIN RECEPTOR 3;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INFANT; MALE; MILROY DISEASE; MISSENSE MUTATION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION;

EID: 77954135825     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ferrell RE, Levinson KL, Esman JH, Kimak MA, Lawrence EC, Barmada MM and Finegold DN: Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet 7: 2073-2078, 1998. (Pubitemid 28546416)
2. OMIM Online Mendelian Inheritance In Man, OMIM (TM). McKusick-Nathans Institute for Genetic Medicine, John Hopkins University (Baltimore, MD) and National Center of Biotechnology Information, National Library of Medicine (Bethesda, MD): Lymphedema, Hereditary, IA. World Wide Web URL:http://www.ncbi. nlm.nih.gov/omim.
3. Leg-Sagie A, Hamani Y, Raas-Rothschild A, Yagel S and Anteby EY: Prenatal ultrasonographic diagnosis of atypical Nonne-Milroy lymphedema. Ultrasound Obstet Gynecol 21: 72-74, 2003.
4. Brouillard P and Vikkula M: Genetic causes of vascular malformations. Hum Mol Genet 16: 140-149, 2007.
5. Malik S and Grezchik KH: Congenital, low penetrance lymphedema of lower limbs maps to chromosome 6q16.2-q22.1 in an inbred Pakistani family. Hum Genet 123: 197-205, 2008.
6. Makhoul IR, Sujov P, Ghanem N and Bronshtein M: Prenatal diagnosis of Milroy's primary congenital lymphedema. Prenat Diagn 22: 823-826, 2002.
7. Connell F, Brice G and Mortimer P: Phenotypic characterization of primary lymphedema. Ann NY Acad Sci 1151: 140-146, 2008.
8. Ghalamkampour A, Morlot S, Raas- Rothschild A, Utkus A, Mulliken JB, Boon LM and Vikkula M: Hereditary lymphedema type I associated with VEGFR 3 mutation: the first de novo case and atypical presentations. Clin Genet 70: 330-335, 2006.
9. Brice G, Child AH, Evans A, Bell R, Mansour S, Burnand K, Sarfarazi M, Jeffery S and Mortimer P: Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet 42: 98-102, 2004.
10. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K and Vikkula M: Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67: 295-301, 2000.
11. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE and Alitalo K: A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 98: 12677-12682, 2000.
12. Evans AL, Bell R, Brice G, Comeglio P, Lipede C, Jeffery S, Mortimer P, Sarfarazi M and Child AH: Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. J Med Genet 40: 697-703, 2003.
13. Mizuno S, Yamada Y, Yamada K, Nomura N and Wakamatsu N: Clinical variability in a Japanese hereditary lymphedema type I family an FLT4 mutation. Congenit Anom (Kyoto) 45: 59-61, 2005.
14. Daniel-Spiegel E, Ghalamkarpour A, Spiegel R, Weiner E, Vikkula M, Shalev E and Shalev SA: Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema. Prenat Diagn 25: 1015-1018, 2005. (Pubitemid 41745679)
15. Butler MG, Dagenais SL, Rockson SG and Glover TW: A novel VEGFR3 mutation causes Milroy disease. Am J Med Genet 143: 1212-1217, 2007.
16. Yu Z, Wang J, Peng S, Dong B and Li Y: Identification of a novel VEGFR-3 missense mutation in a Chinese family with hereditary lymphedema type I. J Genet Genomics 34: 861-867, 2007.
17. Carver C, Brice G, Mansour S, Ostergaard P, Mortimer P and Jeffery S: Three children with Milroy disease and de novo mutations in VEGFR3. Clin Genet 71: 187-189, 2007.
18. Connell FC, Ostergaard P, Carver C, Brice G, Williams N, Mansour S, Mortimer PS and Jeffery S: Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedema. Hum Genet 124: 625-631, 2009.
19. Verstraeten VL, Holnthoner W, van Steensel MA, Veraart JC, Bladergroen RS, Heckman CA, Keskitalo S, Frank J, Alitalo K, Van Geel M and Steijlen PM: Functional analysis of FLT4 mutations with Nonne-Milroy lymphedema. J Invest Dermatol 129: 509-512, 2009.
20. Ghalamkarpour A, Holnthoner W, Saharinen P, Boon LM, Mulliken JB, Alitalo K and Vikkula M: Recessive primary congenital lymphoedema caused by a VEGFR3 mutation. J Med Genet 46: 399-404, 2009.
21. Ghalamkarpour A, Debauche C, Haan E, Van Regemorter N, Sznajer Y, Thomas D, Revencu N, Gillerot Y, Boon LM and Vikkula M: Sporadic in utero generalized edema caused by mutations in the lymphangiogenic genes VEGFR3 and FOXC2. J Pediatr 155: 90-93, 2009.
22. Ferrell RE: Research perspectives in inherited lymphatic disease. Ann NY Acad Sci 979: 39-51, 2002.
23. Tille JC and Pepper MS: Hereditary vascular anomalies. New insights into their pathogenesis. Arterioscler Thromb Vasc Biol 24: 1578-1590, 2004.
24. Tamella T and Alitalo K: Lympangiogenesis: Molecular mechanisms and future promise. Cell 140: 470-476, 2010.
25. Vignes S, Coupé M, Baulieu F and Vaillant L: Limb lymphedema: Diagnosis, explorations, complications. French Lymphology Society. J Mal Vasc 34: 314-322, 2009.
26. Bollinger A and Amann-Vesty BR: Fluorescent microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity. Lymphology 40: 52-62, 2007. (Pubitemid 47257789)
27. Offori TW, Platt CC, Stephens M and Hopkinson GB: Angiosarcoma in congenital hereditary lymphoedema (Milroy's disease)-diagnostic beacons and a review of the literature. Clin Exp Dermatol 18: 174-177, 1993. (Pubitemid 23098413)
28. Méndez R, Capdevilla A, Tellado MG, Somoza I, Liras J, Pais P and Vela D: Kaposiform hemangioendothelioma associated with Milroy's disease (primary hereditary lymphedema). J Pediatr Surg 38: 9-12, 2003.
29. Fink- Puches R, Smolle J, Beham A, Kerl H and Soyer HP: Cutaneous angiosarcoma. Hautarzt 51: 479-485, 2000.
30. Rockson SG: Lymphedema. Am J Med 110: 288-295, 2001.
31. Cheville AL, McGarvey CL, Petrek JA, Russo SA, Taylor ME and Thiadens SR: Lymphedema management. Semin Radiat Oncol 13: 290-301, 2003.
32. Demitras Y, Ozturk N, Yapici O and Topalan M: Comparison of primary and secondary lower-extremity lymphedema treated with supermicrosurgical lymphaticovenous anastomosis and lymphaticovenous implantation. J Reconstr Microsurg 26: 137-143, 2009.
33. Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM and Losordo DW: VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 11: 717-725, 2003.
34. Kaipanen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M and Alitalo K: Expression of the fins-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566-3570, 1995.